Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Medexus Pharmaceuticals Inc (MDP.VN)

Medexus Pharmaceuticals Inc (MDP.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Complete Response Letter Received from FDA for Treosulfan

TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“ Medexus ” or the “ Company ”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”)...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 2.95 (+18.00%)
MEDXF : 2.2400 (+14.87%)
Medexus Appoints New Chief Financial Officer

TORONTO and CHICAGO, July 19, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 2.95 (+18.00%)
MEDXF : 2.2400 (+14.87%)
CDNA : 23.48 (-9.93%)
Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in Canada

TORONTO and CHICAGO and WEDEL, Germany, July 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “ Medexus ”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 2.95 (+18.00%)
MEDXF : 2.2400 (+14.87%)
Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “ Medexus ”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 2.95 (+18.00%)
MEDXF : 2.2400 (+14.87%)
Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021

Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021

MDP.VN : 7.750 (-4.91%)
MDP.TO : 2.95 (+18.00%)
MEDXF : 2.2400 (+14.87%)
Medexus Announces Graduation to the Toronto Stock Exchange

TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV:MDP) (OTCQX: MEDXF) announced today that it has received final...

MDP.VN : 7.750 (-4.91%)
MEDXF : 2.2400 (+14.87%)
Medexus to Present at Raymond James Human Health Innovation Conference

TORONTO, CHICAGO and MONTREAL, June 14, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or  “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731)   announced today...

MDP.VN : 7.750 (-4.91%)
MEDXF : 2.2400 (+14.87%)
Medexus Schedules Fiscal Year 2021 Conference Call

TORONTO and CHICAGO and MONTREAL, June 11, 2021 (GLOBE NEWSWIRE) -- , June 11, 2021 - Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731)...

MDP.VN : 7.750 (-4.91%)
MEDXF : 2.2400 (+14.87%)
Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch

TORONTO, CHICAGO and MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or  “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that...

MDP.VN : 7.750 (-4.91%)
MEDXF : 2.2400 (+14.87%)
Medexus Announces Availability of Triamcinolone Hexacetonide in the United States

TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or  “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731)   announced today...

MDP.VN : 7.750 (-4.91%)
MEDXF : 2.2400 (+14.87%)

Barchart Exclusives

AT&T Stock is Attractive With Its 6.1% Yield and Short Call and Put Income Plays
AT&T stock is attractive to value investors with its 6.1% dividend yield and its low 7x price-to-earnings multiple. In addition investors like its covered call income and short put income plays now. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar